Infliximab is a monoclonal antibody that can counter tumor necrosis factor. Infliximab has been used to treat autoimmune diseases. Researchers have studied the effect of infliximab on depression in patients with cancer, because some depressed patients have an elevated level of inflammatory cytokines.